Regeneron Pharmaceuticals, a maker of synthetic biologic treatments, is acquiring Decibel Therapeutics, developer of gene therapies to treat hearing loss and balance disorders.
Regeneron Pharmaceuticals, a maker of synthetic biologic treatments, is acquiring Decibel Therapeutics, developer of gene therapies to treat hearing loss and balance disorders.
Despite the progress in our approach to achieve HC regeneration in the adult #cochlea in vitro and in vivo, major challenges remain before potential clinical applications. Always read the main paper as a commen in #hackernews suggests. #acoustics https://news.ycombinator.com/item?id=35895417&utm_term=comment